Viking Therapeutics (VKTX) Amortizatization of Intangibles (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Amortizatization of Intangibles for 13 consecutive years, with $85000.0 as the latest value for Q1 2026.

  • For Q1 2026, Amortizatization of Intangibles fell 23.42% year-over-year to $85000.0; the TTM value through Mar 2026 reached $9.3 million, down 46.5%, while the annual FY2025 figure was $9.3 million, 46.23% down from the prior year.
  • Amortizatization of Intangibles hit $85000.0 in Q1 2026 for Viking Therapeutics, down from $8.9 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $17.0 million in Q4 2024 and bottomed at -$8.0 million in Q3 2024.
  • Average Amortizatization of Intangibles over 5 years is $1.5 million, with a median of $85000.0 recorded in 2026.
  • Year-over-year, Amortizatization of Intangibles crashed 1030.56% in 2022 and then soared 22914.86% in 2024.
  • Viking Therapeutics' Amortizatization of Intangibles stood at -$1.4 million in 2022, then surged by 105.15% to $74000.0 in 2023, then skyrocketed by 22914.86% to $17.0 million in 2024, then plummeted by 47.47% to $8.9 million in 2025, then tumbled by 99.05% to $85000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $85000.0, $8.9 million, and $114000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.